Style | Citing Format |
---|---|
MLA | Mohabati Mobarez A, et al.. "Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins." European Journal of Pharmaceutics and Biopharmaceutics, vol. 155, no. , 2020, pp. 69-76. |
APA | Mohabati Mobarez A, Soleimani N, Esmaeili SA, Farhangi B (2020). Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins. European Journal of Pharmaceutics and Biopharmaceutics, 155(), 69-76. |
Chicago | Mohabati Mobarez A, Soleimani N, Esmaeili SA, Farhangi B. "Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins." European Journal of Pharmaceutics and Biopharmaceutics 155, no. (2020): 69-76. |
Harvard | Mohabati Mobarez A et al. (2020) 'Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins', European Journal of Pharmaceutics and Biopharmaceutics, 155(), pp. 69-76. |
Vancouver | Mohabati Mobarez A, Soleimani N, Esmaeili SA, Farhangi B. Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins. European Journal of Pharmaceutics and Biopharmaceutics. 2020;155():69-76. |
BibTex | @article{ author = {Mohabati Mobarez A and Soleimani N and Esmaeili SA and Farhangi B}, title = {Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {155}, number = {}, pages = {69-76}, year = {2020} } |
RIS | TY - JOUR AU - Mohabati Mobarez A AU - Soleimani N AU - Esmaeili SA AU - Farhangi B TI - Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins JO - European Journal of Pharmaceutics and Biopharmaceutics VL - 155 IS - SP - 69 EP - 76 PY - 2020 ER - |